Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody

This publication has 25 references indexed in Scilit:

• C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Epidermal growth factor receptor signaling
  Current Biology, 2001
• The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.
  Endocrine-Related Cancer, 2001
• Growth Factors in Development and Diseases of the Exocrine Pancreas
  Pancreatology, 2001
• NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
  The EMBO Journal, 2000
• Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice
  Cancer, 2000
• Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and Radiation
  Cancer Biotherapy & Radiopharmaceuticals, 1999
• Molecular Aspects of Pancreatic Cancer and Future Perspectives
  Digestive Surgery, 1999
• Comparative Phenotypic Studies of Duct Epithelial Cell Lines Derived from Normal Human Pancreas and Pancreatic Carcinoma
  The American Journal of Pathology, 1998
• Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy
  International Journal of Cancer, 1997